J 2015

Increased Cardio-ankle Vascular Index in Hyperlipidemic Patients without Diabetes or Hypertension

DOBŠÁK, Petr, Vladimír SOŠKA, Ondřej SOCHOR, Jiří JARKOVSKÝ, Marie NOVÁKOVÁ et. al.

Základní údaje

Originální název

Increased Cardio-ankle Vascular Index in Hyperlipidemic Patients without Diabetes or Hypertension

Autoři

DOBŠÁK, Petr (203 Česká republika, domácí), Vladimír SOŠKA (203 Česká republika, garant, domácí), Ondřej SOCHOR (203 Česká republika), Jiří JARKOVSKÝ (203 Česká republika, domácí), Marie NOVÁKOVÁ (203 Česká republika, domácí), Martin HOMOLKA (203 Česká republika), Miroslav SOUČEK (203 Česká republika, domácí), Petra PALANOVÁ (203 Česká republika, domácí), Francisco LOPEZ-JIMENEZ (840 Spojené státy) a Kohji SHIRAI (392 Japonsko)

Vydání

Journal of Atherosclerosis and Thrombosis, Tokyo, Japan Atherosclerosis Society, 2015, 1340-3478

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Japonsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.411

Kód RIV

RIV/00216224:14110/15:00085181

Organizační jednotka

Lékařská fakulta

UT WoS

000352271200008

Klíčová slova anglicky

Cardio-ankle vascular index; Combined hyperlipidemia; Hypercholesterolemia

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 27. 1. 2016 12:01, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Aim: The cardio-ankle vascular index (CAVI) is a sensitive non-invasive marker of arterial stiffness and atherosclerosis. The aim of this work was to compare the CAVI values in patients with dyslipidemia (without diabetes mellitus and hypertension) and healthy controls. Methods: A Total 248 subjects with dyslipidemia (104 men, 144 women), 55.0 (95% CI 30-70) years of age with combined hyperlipidemia or primary hypercholesterolemia and 537 healthy controls (244 men, 293 women) 40.0 (95% CI 26-62) years of age were included in this study. Fasting blood samples were collected to measure the serum total cholesterol, triglyceride, HDL-cholesterol and apolipoprotein A1 and B levels. The LDL cholesterol level was also calculated, and the CAVI was measured using the VaSera (R) 1500 system. Results: The CAVI values were significantly higher in the dyslipidemic patients (8.08, 95% CI 6.00-10.05) than in the controls (7.11, 95% CI 5.77-9.05; p<0.01). In addition, the CAVI values were elevated in both subgroups of patients with hypercholesterolemia (7.95, 95% CI 5.85-6.90; p<0.01) and combined hyperlipidemia (8.30, 95% CI 6.60-10.15; p<0.01) in comparison with those observed in the controls. After adopting the propensity score method in order to balance the confounding factors (age, gender, body mass index) and adjust the analysis for diastolic blood pressure, the CAVI values in the dyslipidemic patients remained significantly high (7.78, 95% CI 5.80-9.69) compared to that observed in the controls (7.31, 95% CI 5.44-9.35; p<0.001). However, the CAVI values did not differ significantly between the controls and both subgroups of dyslipidemic patients (primary hypercholesterolemia, combined hyperlipidemia). Conclusions: The present findings demonstrated that dyslipidemia increases the CAVI values in comparison to that seen in healthy subjects.